Figure 1
![Figure 1. Pim kinases in cancer. (A) Pim kinase pathways (adapted from Chen et al26). (B) Chemical structure of imidazo[1,2-b]pyridazine compound SGI-1776.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/118/3/10.1182_blood-2010-12-323022/4/zh89991174840001.jpeg?Expires=1722775654&Signature=EE~jxR18V8hNWTvPKREGaTI3oB8oMdGrMysl02VVFtD1xFAVB2wJlV-gouljpbctMcJNZwB5Bo81cVkXEtSPtv2lwq6EezGRw-Jv1HuircoK5KIfc3vTKah5YbPEVhiTJRKV1wBtvasz9tes-4k4rySWgCtAl-~Jk6pytwPAoNffbAr0-TJZPICNQU4TIBFvaxMf4ss45-MO9O7aIGJzsbqLdfBjBWvsJA81JNfb-KSSMLtKTH5FjGDeCXg6xfBH4JcCoKgz0Cq~tktNE8sfY03UibtZO0W4JNvqOVkLUpfV3v7RQgG32EuPoA4xGZjCa~0enc73CdZd28rM1l4dGw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Pim kinases in cancer. (A) Pim kinase pathways (adapted from Chen et al26). (B) Chemical structure of imidazo[1,2-b]pyridazine compound SGI-1776.
Pim kinases in cancer. (A) Pim kinase pathways (adapted from Chen et al26). (B) Chemical structure of imidazo[1,2-b]pyridazine compound SGI-1776.
